SAMLYN CAPITAL, LLC

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Vinci Compass Investments Ltd. 13G VINP · G9451V109	VINP	G9451V109	6.0%	3,036,724	13G	8/14/2026 Event 6/30/2026
Samlyn Capital, LLC			6.0%	3,036,724
Samlyn, LP			6.0%	3,036,724
Robert Pohly			6.0%	3,036,724
PureCycle Technologies, Inc. 13G/A PCT · 74623V103	PCT	74623V103	4.2%	7,896,848	13G/A	5/15/2026 Event 3/31/2026
Samlyn Capital, LLC			4.2%	7,896,848
Samlyn, LP			4.2%	7,896,848
Robert Pohly			4.2%	7,896,848
Corvus Pharmaceuticals, Inc. 13G/A CRVS · 221015100	CRVS	221015100	0%	0	13G/A	8/14/2025 Event 6/30/2025
Samlyn Capital, LLC			0%	0
Samlyn, LP			0%	0
Robert Pohly			0%	0
Nektar Therapeutics 13G/A NKTR · 640268108	NKTR	640268108	0%	0	13G/A	5/15/2025 Event 3/31/2025
Samlyn Capital, LLC			0%	0
Samlyn, LP			0%	0
Robert Pohly			0%	0
Inozyme Pharma, Inc. 13G/A INZY · 45790W108	INZY	45790W108	0%	0	13G/A	2/14/2025 Event 12/31/2024
Samlyn Capital, LLC			0%	0
Samlyn, LP			0%	0
Robert Pohly			0%	0